Wikidata

(Q61969155)

English

Study of Efficacy and Safety of Vildagliptin as add-on Insulin Therapy in T2DM Patients

clinical trial

In more languages

Statements

title
A 12-week, Multi-center, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Assess the Efficacy and Safety of Equa (Vildagliptin) 50 mg Bid as an add-on Therapy to Insulin, With or Without Metformin, in Patients With Type 2 Diabetes Mellitus (English)
0 references
sponsor
Novartis
0 references
country
Japan
0 references
start time
December 2013
0 references
end time
February 2015
0 references
number of participants
156
0 references
research intervention
vildagliptin
0 references
metformin
0 references
research site
Novartis
0 references
minimum age
20 year
0 references
maximum age
74 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q61969155&oldid=2091084279"